Flavia Pease Charles River Laboratories International, Inc. (CRL) insider trading activity

Flavia Pease is Corporate Executive VP & CFO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 17,297 shares of CRL, which is worth approximately $2.61 Million. The most recent transaction as insider was on May 31, 2025, when has been sold 185 shares (Common Stock) at a price of $135.63 per share, resulting in proceeds of $25,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.3K

49.76% 3M change

77.22% 12M change

Total Value Held $2.61 Million

Flavia Pease Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2025	SELL Payment of exercise price or tax liability	$25,091 $135.63 p/Share	185 Reduced 1.06%	17,297 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$970,025 $135.63 p/Share	7,152 Added 29.03%	17,482 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$19,278 $136.73 p/Share	141 Reduced 1.35%	10,330 Common Stock
May 26 2025	SELL Payment of exercise price or tax liability	$25,978 $136.73 p/Share	190 Reduced 1.78%	10,471 Common Stock
May 02 2025	SELL Payment of exercise price or tax liability	$103,915 $116.89 p/Share	889 Reduced 7.7%	10,661 Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$151,330 $165.57 p/Share	914 Reduced 7.33%	11,550 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	2,704 Added 17.83%	12,464 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	2,159 Added 18.11%	9,760 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$31,278 $217.21 p/Share	144 Reduced 1.85%	7,651 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$46,048 $217.21 p/Share	212 Reduced 2.65%	7,795 Common Stock
May 02 2024	SELL Payment of exercise price or tax liability	$207,792 $232.69 p/Share	893 Reduced 10.03%	8,007 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$26,594 $194.12 p/Share	137 Reduced 1.52%	8,900 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	2,215 Added 19.69%	9,037 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	1,637 Added 19.35%	6,822 Common Stock
May 02 2022	BUY Grant, award, or other acquisition	-	5,185 Added 50.0%	5,185 Common Stock

Also insider at

PODD

INSULET CORP Healthcare

Director

Flavia Pease

Corporate Executive VP & CFO

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account